Zevra Therapeutics Inc (ZVRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,308 | 13,438 | 18,409 | 2,888 | 17,597 |
| Marketable Securities | N/A | N/A | 3,260 | 11,239 | 11,702 |
| Receivables | N/A | N/A | 140 | N/A | N/A |
| TOTAL | $8,640 | $15,311 | $23,721 | $16,737 | $30,909 |
| Non-Current Assets | |||||
| PPE Net | 1,613 | 1,688 | 1,753 | 1,817 | 1,841 |
| Other Non-Current Assets | 2,756 | 2,868 | 1,272 | 183 | 1,250 |
| TOTAL | $4,369 | $4,556 | $3,025 | $2,000 | $3,091 |
| Total Assets | $13,009 | $19,867 | $26,746 | $18,737 | $34,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,862 | 8,178 | 8,342 | 14,677 | 13,967 |
| Other current liabilities | 222 | 229 | 115 | 103 | 113 |
| TOTAL | $14,975 | $15,172 | $12,004 | $18,323 | $17,603 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 79,581 | 79,531 | 80,912 | 95,308 | 99,476 |
| TOTAL | $79,581 | $79,531 | $81,308 | $95,759 | $99,942 |
| Total Liabilities | $94,556 | $94,703 | $93,312 | $114,082 | $117,545 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,860 | 1,782 | 1,653 | 1,653 | 1,003 |
| Common Shares | 3 | 3 | 3 | 2 | 2 |
| Retained earnings | -242,740 | -233,483 | -221,192 | -216,009 | -200,938 |
| TOTAL | $-81,547 | $-74,836 | $-66,566 | $-95,345 | $-83,545 |
| Total Liabilities And Equity | $13,009 | $19,867 | $26,746 | $18,737 | $34,000 |